Similar immunogenicity profiles between the proposed biosimilar MYL-1501D and reference insulin glargine in patients with diabetes mellitus: the phase 3 INSTRIDE 1 and INSTRIDE 2 studies
在糖尿病患者中，拟上市的生物类似药MYL-1501D与参考胰岛素甘精具有相似的免疫原性特征：3期INSTRIDE 1和INSTRIDE 2研究
期刊:BMC Endocrine Disorders
影响因子:3.3
doi:10.1186/s12902-021-00797-4
Sun, Bin; Sengupta, Nilanjan; Rao, Anita; Donnelly, Charles; Waichale, Vinit; Roy, Arnab Sinha; Ramaswamy, Shilpa; Pathak, Divya; Bowsher, Ronald R; Raiter, Yaron; Aubonnet, Patrick; Barve, Abhijit
